GO:1903790 guanine nucleotide transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903790 describes the biological process in which a guanyl nucleotide is transported across a membrane.
• Guanine nucleotide transmembrane transport is essential for cyclic nucleotide signaling, membrane guanylyl cyclase receptor function, and ion channel gating.
• Key proteins include membrane guanylyl cyclases (GUCY2C, GUCY2D, NPR1, NPR2), cyclic-nucleotide-gated channels (CNGA1, CNGB1, HCN1, HCN2), and RAB GTPases (RAB7, RAB8, RAB11) that coordinate vesicular transport.
• Dysregulation of guanine nucleotide transport is linked to intestinal disorders, retinal degeneration, cardiovascular disease, and viral pathogenesis.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise dissection of guanine nucleotide transport mechanisms.
• EDITGENE provides end-to-end CRISPR services including library screening and bioinformatics to accelerate research on GO:1903790-related genes.
Description
Guanine nucleotide transmembrane transport (GO:1903790) is the process by which guanyl nucleotides are moved across a membrane. This process is fundamental to cellular signaling because guanine nucleotides such as cyclic GMP (cGMP) and cyclic AMP (cAMP) act as second messengers that regulate diverse physiological functions, including vision, olfaction, cardiac rhythm, and intestinal secretion. The transport of these nucleotides across membranes is tightly coupled to the activity of membrane guanylyl cyclase receptors and cyclic-nucleotide-gated channels, which convert extracellular signals into intracellular responses. Researchers study GO:1903790 to understand how cells control the spatial and temporal distribution of guanine nucleotides, which is critical for signal transduction fidelity. Defects in guanine nucleotide transport have been implicated in diseases ranging from enterotoxigenic infections to retinal degeneration and cardiovascular disorders. Moreover, recent studies on unconventional protein secretion and viral pathogenesis have revealed that RAB GTPases, which bind guanine nucleotides, coordinate membrane trafficking events that intersect with nucleotide transport pathways. The integration of CRISPR-based genome editing with advanced biochemical and imaging techniques now allows precise interrogation of the genes and mechanisms underlying guanine nucleotide transmembrane transport. This article synthesizes current knowledge from authoritative QuickGO annotations and peer-reviewed literature to provide a research-grade overview of GO:1903790, its molecular components, disease relevance, and experimental strategies.
guanine nucleotide transmembrane transport At A Glance
| GO ID | GO:1903790 |
|---|---|
| GO term | guanine nucleotide transmembrane transport |
| Ontology | biological_process |
| Synonym | guanyl nucleotide transmembrane transport |
| Major function | Transport of guanyl nucleotides across membranes, enabling cyclic nucleotide signaling and membrane guanylyl cyclase receptor function. |
| Related cellular components | Plasma membrane, vesicular membranes, Golgi, endoplasmic reticulum. |
| Related molecular functions | Guanylyl cyclase activity, cyclic-nucleotide-gated channel activity, GTPase activity. |
| Key regulators | Membrane guanylyl cyclase receptors (GUCY2C, GUCY2D), cyclic-nucleotide-gated channels (CNGA1, CNGB1), RAB GTPases. |
| Disease associations | Intestinal secretory diarrhea, retinal degeneration, cardiovascular disease, viral pathogenesis. |
What Is GO:1903790?
According to the Gene Ontology, GO:1903790 (guanine nucleotide transmembrane transport) is defined as the process in which a guanyl nucleotide is transported across a membrane. This encompasses the movement of guanine-based nucleotides, such as GTP, GDP, cGMP, and their derivatives, from one side of a lipid bilayer to the other. The process may occur through dedicated transporters, channels, or via vesicular trafficking pathways that shuttle nucleotides between cellular compartments.
Why Is guanine nucleotide transmembrane transport Important in Cell Biology?
Guanine nucleotide transmembrane transport is critical for converting extracellular signals into intracellular responses through cyclic nucleotide second messengers. This process underpins sensory perception, fluid homeostasis, and cardiac function, and its dysregulation contributes to a wide range of pathologies including diarrheal diseases, blindness, and heart failure. Understanding the molecular players and regulatory mechanisms of GO:1903790 is therefore essential for developing targeted therapies and for interpreting genetic variants associated with these conditions.
• Enables cyclic GMP and cyclic AMP signaling across membranes, which is essential for vision, olfaction, and cardiovascular regulation.
• Membrane guanylyl cyclase receptors such as GUCY2C and GUCY2D produce cGMP that must be transported to activate downstream effectors.
• Cyclic-nucleotide-gated channels require guanine nucleotide transport for proper gating and ion flux.
• RAB GTPases coordinate vesicular trafficking of guanine nucleotide transporters and channels.
• Dysregulation of guanine nucleotide transport is linked to enterotoxigenic diarrhea and intestinal inflammatory disorders.
• Mutations in genes involved in this process cause retinal degeneration and cardiovascular disease.
• Viral pathogens such as African swine fever virus and TBEV manipulate guanine nucleotide-dependent trafficking to evade host defenses.
• CRISPR screens can identify novel regulators of guanine nucleotide transmembrane transport.
• The process is a potential therapeutic target for modulating cyclic nucleotide levels in disease.
• Bioinformatics integration of GO annotations with expression data reveals tissue-specific transport mechanisms.
What Happens During guanine nucleotide transmembrane transport?
Synthesis and availability of guanine nucleotides
In simple terms: The cell first makes guanine nucleotides like cGMP and cAMP.
Guanine nucleotide transmembrane transport depends on the availability of guanyl nucleotides, which are synthesized by enzymes such as membrane guanylyl cyclases (e.g., GUCY2C, GUCY2D) that convert GTP to cGMP at the plasma membrane. These cyclases are activated by extracellular ligands including natriuretic peptides and bacterial enterotoxins, leading to localized bursts of cGMP production. The newly synthesized cGMP can then be transported across membranes or act on nearby effectors.
Transport across the plasma membrane
In simple terms: Guanine nucleotides move across the cell membrane through channels or transporters.
Cyclic-nucleotide-gated channels, such as CNGA1 and CNGB1 in photoreceptors, mediate the transmembrane flux of cyclic nucleotides and ions in response to changes in cGMP levels. These channels are non-selective cation channels whose opening is directly controlled by the binding of cGMP, which itself must be transported or generated near the membrane. The transport process ensures that cyclic nucleotides reach their intracellular targets, including protein kinase G and cyclic-nucleotide-gated channels.
Vesicular trafficking and membrane fusion
In simple terms: Guanine nucleotides are also moved inside cells by vesicles that fuse with membranes.
RAB GTPases, which are small guanine nucleotide-binding proteins, regulate vesicular trafficking of transporters and channels to and from the plasma membrane. For example, RAB-8 and RAB-11 coordinate unconventional protein secretion, a process that involves the transport of cargo across membranes. Similarly, African swine fever virus I10L protein disrupts RAB7-HOPS complex-dependent SNARE assembly, impairing autolysosome formation and altering guanine nucleotide-dependent membrane dynamics. These findings highlight that guanine nucleotide transmembrane transport is intimately linked to vesicle-mediated membrane remodeling.
Regulation by guanine nucleotide exchange and hydrolysis
In simple terms: The transport process is switched on and off by proteins that bind and break down GTP.
Guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) control the cycling of RAB GTPases between active GTP-bound and inactive GDP-bound states, thereby regulating the timing and location of membrane transport events. Membrane guanylyl cyclase receptors also possess intrinsic guanylyl cyclase activity that is modulated by ATP and other nucleotides, linking nucleotide metabolism to transport. The interplay between synthesis, transport, and hydrolysis ensures precise spatiotemporal control of guanine nucleotide signaling.
Integration with cellular signaling pathways
In simple terms: Guanine nucleotide transport is connected to many other cellular signals.
Guanine nucleotide transmembrane transport intersects with calcium signaling, protein kinase pathways, and gene expression programs. For instance, cyclic-nucleotide-gated channels allow calcium influx upon cGMP binding, which can further modulate transport activity and gene transcription. In TBEV-infected neurons and astrocytes, integrative RNA profiling revealed altered expression of genes involved in nucleotide transport and signaling, suggesting that viral infection reprograms these pathways. Thus, GO:1903790 is a hub process that integrates diverse cellular inputs.
Key Genes Involved in GO:1903790 guanine nucleotide transmembrane transport
The following genes encode proteins that directly or indirectly participate in guanine nucleotide transmembrane transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GUCY2C | Membrane guanylyl cyclase receptor that synthesizes cGMP; involved in intestinal fluid secretion | Target for diarrhea and colorectal cancer studies |
| GUCY2D | Retinal guanylyl cyclase that produces cGMP for phototransduction | Mutations cause Leber congenital amaurosis; model for retinal degeneration |
| NPR1 | Natriuretic peptide receptor A with guanylyl cyclase activity; produces cGMP | Cardiovascular disease and hypertension research |
| NPR2 | Natriuretic peptide receptor B; involved in skeletal growth and cGMP signaling | Model for dwarfism and bone disorders |
| CNGA1 | Cyclic-nucleotide-gated channel subunit in rod photoreceptors; binds cGMP | Retinitis pigmentosa and channelopathy studies |
| CNGB1 | Cyclic-nucleotide-gated channel subunit in rod photoreceptors; modulates channel gating | Retinal degeneration models |
| HCN1 | Hyperpolarization-activated cyclic nucleotide-gated channel; regulates cardiac and neuronal pacemaking | Epilepsy and arrhythmia research |
| HCN2 | Cyclic nucleotide-gated channel involved in neuronal excitability and pain | Neuropathic pain models |
| RAB7 | Late endosomal GTPase; regulates autolysosome formation and membrane fusion | Viral pathogenesis and autophagy studies |
| RAB8 | GTPase involved in unconventional protein secretion and vesicle trafficking | Protein secretion and membrane transport research |
| RAB11 | Recycling endosome GTPase; coordinates vesicle transport | Cell polarity and secretion studies |
| HOPS complex subunits (VPS11, VPS16, VPS18, VPS33, VPS39, VPS41) | Tethering complex that interacts with RAB7 for SNARE assembly | Autophagy and lysosome fusion research |
| SNARE proteins (e.g., STX17, VAMP8) | Mediate membrane fusion downstream of RAB7-HOPS | Membrane trafficking and viral evasion studies |
| GTPase-activating proteins (GAPs) | Inactivate RAB GTPases by stimulating GTP hydrolysis | Regulation of transport timing |
| Guanine nucleotide exchange factors (GEFs) | Activate RAB GTPases by promoting GDP-to-GTP exchange | Spatial control of membrane transport |
| Cyclic nucleotide phosphodiesterases (PDEs) | Degrade cGMP and cAMP, terminating signals | Drug targets for cardiovascular and retinal diseases |
| ATP-binding cassette transporters (e.g., ABCC4, ABCC5) | Transport cyclic nucleotides across membranes | Pharmacology and multidrug resistance research |
| SLC transporters (e.g., SLC22A, SLC29A) | Facilitate nucleoside and nucleotide transport | Nucleotide homeostasis studies |
How Is guanine nucleotide transmembrane transport Regulated?
Guanine nucleotide transmembrane transport is regulated at multiple levels. Membrane guanylyl cyclase receptors are controlled by extracellular ligands such as natriuretic peptides and bacterial enterotoxins, which modulate cGMP synthesis and subsequent transport. RAB GTPases are regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) that dictate their active and inactive states, thereby controlling vesicular transport of channels and transporters. Additionally, cyclic nucleotide phosphodiesterases hydrolyze cGMP and cAMP, limiting the pool of nucleotides available for transport. Post-translational modifications, including phosphorylation, further tune the activity of cyclic-nucleotide-gated channels and transporters. In viral infections, proteins such as African swine fever virus I10L disrupt RAB7-HOPS-dependent SNARE assembly, thereby altering membrane transport regulation.
guanine nucleotide transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GUCY2C | Secretory diarrhea, colorectal cancer | Intestinal organoids, KO mice |
| GUCY2D | Leber congenital amaurosis, retinal degeneration | Retinal explants, knock-in mice |
| CNGA1 | Retinitis pigmentosa | Photoreceptor cell lines, KO mice |
| CNGB1 | Retinal degeneration | Retinal organoids, KO mice |
| RAB7 | Viral pathogenesis, autophagy defects | HeLa cells, KO cell lines |
Intestinal secretory diarrhea and inflammatory disorders
Enterotoxigenic bacteria produce heat-stable enterotoxins that activate GUCY2C, leading to excessive cGMP production and transport, which drives chloride and fluid secretion into the intestinal lumen. This mechanism underlies secretory diarrhea, a major cause of morbidity worldwide. Dysregulation of guanine nucleotide transport also contributes to inflammatory bowel diseases, where altered cGMP signaling affects epithelial barrier function.
Retinal degeneration and blindness
Mutations in GUCY2D and CNGA1/CNGB1, which are essential for cGMP synthesis and transport in photoreceptors, cause Leber congenital amaurosis and retinitis pigmentosa. Defective guanine nucleotide transport impairs phototransduction, leading to progressive loss of vision. Animal models with targeted mutations in these genes are widely used to study retinal degeneration.
Cardiovascular disease
Natriuretic peptide receptors NPR1 and NPR2 produce cGMP that regulates vascular tone, cardiac hypertrophy, and fluid balance. Impaired transport or signaling of cGMP contributes to hypertension, heart failure, and myocardial infarction. Pharmacological agents that modulate cGMP levels, such as phosphodiesterase inhibitors, are used clinically, highlighting the importance of guanine nucleotide transport in cardiovascular medicine.
Viral pathogenesis and immune evasion
Viruses such as African swine fever virus and tick-borne encephalitis virus manipulate guanine nucleotide-dependent membrane trafficking to evade host immunity. African swine fever virus I10L protein disrupts RAB7-HOPS complex-dependent SNARE assembly, inhibiting autolysosome formation and promoting viral survival. TBEV infection alters RNA profiles of neurons and astrocytes, affecting nucleotide transport and signaling pathways. These examples illustrate how pathogens hijack GO:1903790-related processes.
From guanine nucleotide transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GUCY2C affect cGMP transport and intestinal secretion? | CRISPR knockout intestinal epithelial cells or organoids |
| How do point mutations in CNGA1 alter channel gating and cGMP transport? | Point-mutation knock-in in photoreceptor cell lines |
| Can tagged GUCY2D reveal real-time cGMP transport dynamics? | Knock-in of fluorescent tag in retinal cells |
| Does overexpression of RAB7 enhance autolysosome formation? | Overexpression in HeLa or HEK293 cells |
| What genes regulate guanine nucleotide transport in neurons? | CRISPR library screening in neuronal cell lines |
| How does TBEV infection alter nucleotide transport gene expression? | RNA-seq of infected neurons and astrocytes |
How to Study the guanine nucleotide transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects on transport | Identifying essential genes |
| Point mutation knock-in | Effect of specific variants on transport activity | Disease variant modeling |
| Tagged knock-in | Localization and dynamics of transport proteins | Live-cell imaging |
| Overexpression | Gain-of-function and rescue | Dominant-negative studies |
| RNA-seq | Transcriptional changes in transport genes | Viral infection and disease models |
| Proteomics | Protein interactions and abundance | Complex composition analysis |
| CRISPR library screening | Genome-wide regulators of transport | Target discovery |
| Bioinformatics (QuickGO, pathway analysis) | Functional annotation and enrichment | Systems-level interpretation |
CRISPR knockout and point-mutation models
CRISPR-Cas9 knockout of genes such as GUCY2C, CNGA1, or RAB7 allows researchers to assess loss-of-function effects on guanine nucleotide transport. Point mutations can be introduced to mimic disease-associated variants, enabling structure-function studies of transporters and channels. These models are essential for establishing causality between specific genes and transport phenotypes.
Knock-in and tagged knock-in reporters
Knock-in of fluorescent or affinity tags into endogenous loci (e.g., GUCY2D, CNGB1) enables real-time imaging and biochemical purification of transport complexes. Tagged knock-in models preserve native expression patterns and regulatory sequences, providing physiologically relevant insights. Such models are particularly useful for studying membrane trafficking and localization.
Overexpression and rescue experiments
Overexpression of wild-type or mutant forms of RAB GTPases, guanylyl cyclases, or cyclic-nucleotide-gated channels can reveal gain-of-function effects and rescue phenotypes in knockout backgrounds. These experiments help dissect domain-specific functions and identify dominant-negative variants.
Library screening and bioinformatics
Genome-wide CRISPR library screening combined with RNA-seq or proteomics can identify novel regulators of guanine nucleotide transmembrane transport. Bioinformatics integration of GO annotations, expression data, and pathway databases (e.g., QuickGO) provides systems-level insights into transport networks. These approaches are powerful for discovering therapeutic targets.
How CRISPR Can Be Used to Study GO:1903790 guanine nucleotide transmembrane transport
Knockout
CRISPR knockout of genes such as GUCY2C, CNGA1, or RAB7 is used to abolish protein function and assess the consequences for guanine nucleotide transmembrane transport. Knockout cell lines and animal models reveal whether a gene is required for cGMP production, channel gating, or vesicular trafficking. These models are foundational for target validation in disease contexts.
Point Mutation
Point mutations can be introduced via CRISPR base editing or homology-directed repair to mimic disease-associated missense variants in transport proteins. Such models allow precise interrogation of how single amino acid changes affect nucleotide binding, transport kinetics, and channel gating. They are particularly valuable for studying retinal degeneration and channelopathies.
Knock-in
Knock-in of reporter tags (e.g., GFP, HA) or disease alleles into endogenous loci enables visualization and biochemical analysis of transport proteins at physiological expression levels. Tagged knock-in models are ideal for tracking membrane trafficking and interactions in real time. They also facilitate drug screening by providing quantifiable readouts.
Overexpression
Overexpression of wild-type or mutant transport proteins (e.g., RAB7, GUCY2C) in cell lines can enhance or disrupt transport pathways, revealing gain-of-function phenotypes and dominant-negative effects. Overexpression models are useful for biochemical purification and structural studies. They complement knockout approaches by providing complementary loss- and gain-of-function data.
How EDITGENE Supports guanine nucleotide transmembrane transport Research
Researchers studying guanine nucleotide transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in transport, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional interrogation of GO:1903790-associated pathways.
Contact EDITGENE today to design your custom CRISPR model for guanine nucleotide transmembrane transport research.
Frequently Asked Questions About guanine nucleotide transmembrane transport
What is guanine nucleotide transmembrane transport?
Guanine nucleotide transmembrane transport (GO:1903790) is the biological process in which a guanyl nucleotide is transported across a membrane, as defined by the Gene Ontology.
What genes are involved in guanine nucleotide transmembrane transport?
Key genes include GUCY2C, GUCY2D, NPR1, NPR2, CNGA1, CNGB1, HCN1, HCN2, RAB7, RAB8, and RAB11, among others.
How does guanine nucleotide transport relate to cyclic GMP signaling?
Membrane guanylyl cyclases produce cGMP, which must be transported across membranes to activate cyclic-nucleotide-gated channels and other effectors.
What diseases are associated with defects in guanine nucleotide transport?
Defects are linked to secretory diarrhea, retinal degeneration, cardiovascular disease, and viral pathogenesis.
How can CRISPR be used to study guanine nucleotide transmembrane transport?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes involved in transport, enabling functional studies.
What is the role of RAB GTPases in guanine nucleotide transport?
RAB GTPases regulate vesicular trafficking and membrane fusion events that transport channels and transporters, thereby influencing guanine nucleotide transport.
Which experimental models are best for studying GO:1903790?
Cell lines, organoids, and animal models with CRISPR edits in genes such as GUCY2C, CNGA1, and RAB7 are commonly used.
How does TBEV infection affect guanine nucleotide transport?
TBEV infection alters RNA profiles of neurons and astrocytes, affecting nucleotide transport and signaling pathways.
What methods measure guanine nucleotide transmembrane transport?
Methods include RNA-seq, proteomics, live-cell imaging with tagged knock-ins, and CRISPR library screening.
Can EDITGENE help create custom models for guanine nucleotide transport research?
Yes, EDITGENE offers knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to GO:1903790-related genes.
Conclusion
Guanine nucleotide transmembrane transport (GO:1903790) is a fundamental biological process that governs cyclic nucleotide signaling, membrane trafficking, and cellular responses to external stimuli. Its dysregulation contributes to diverse diseases, including secretory diarrhea, retinal degeneration, cardiovascular disorders, and viral pathogenesis. Advances in CRISPR genome editing and functional genomics now enable precise dissection of the genes and mechanisms underlying this process. By leveraging these tools, researchers can uncover new therapeutic targets and deepen our understanding of guanine nucleotide transport in health and disease.
References
- 1. Gemmer M et al.. 2023. Visualization of translation and protein biogenesis at the ER membrane.. Nature 614(7946):160-167 PMID: 36697828
- 2. Selinger M et al.. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.. Comput Struct Biotechnol J 20:2759-2777 PMID: 35685361
- 3. Li X et al.. 2024. Coordination of RAB-8 and RAB-11 during unconventional protein secretion.. J Cell Biol 223(2) PMID: 38019180
- 5. Chen M et al.. 2026. African swine fever virus I10L protein inhibits autolysosome formation by disrupting RAB7-HOPS complex-dependent SNARE complex assembly.. Autophagy 22(9):2216-2231 PMID: 42138513
- 6. Fleckenstein JM et al.. 2021. Changing the locks on intestinal signaling.. Cell Host Microbe 29(9):1335-1337 PMID: 34499858
- 7. Li M et al.. 2017. Structure of a eukaryotic cyclic-nucleotide-gated channel.. Nature 542(7639):60-65 PMID: 28099415
- 8. Kuhn M. 2016. Molecular Physiology of Membrane Guanylyl Cyclase Receptors.. Physiol Rev 96(2):751-804 PMID: 27030537
